## Core Concept
Heparin-induced thrombocytopenia (HIT) is a serious immune-mediated disorder that occurs in some patients treated with heparin. It is characterized by a significant drop in platelet count (thrombocytopenia) and an increased risk of thrombosis. The condition arises due to the formation of antibodies against the heparin-platelet factor 4 complex.

## Why the Correct Answer is Right
The correct answer, ., implies that the statement regarding HIT syndrome that is not true needs to be identified among the options. Typically, HIT syndrome involves a decrease in platelet count (thrombocytopenia), and it paradoxically leads to a prothrombotic state. The antibodies formed activate platelets, leading to their consumption and the release of procoagulant microparticles, which increases the risk of venous or arterial thrombosis.

## Why Each Wrong Option is Incorrect
- **Option A:** Typically, HIT occurs after several days of heparin therapy, but it can happen sooner if there was recent heparin exposure within the past 100 days. This statement might be true about HIT.
- **Option B:** HIT is associated with a high risk of thrombosis, not just bleeding. This prothrombotic state is a hallmark of the syndrome.
- **Option C:** The condition is caused by antibodies against the heparin-platelet factor 4 complex, making it an immune-mediated process. This is a true statement about the pathophysiology of HIT.
- **Option D:** Given that HIT involves thrombocytopenia and a paradoxical increase in thrombotic events, any statement contradicting these facts would be incorrect.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that HIT syndrome is often remembered by the "4 Ts": **Thrombocytopenia**, **Timing** of heparin exposure, **Thrombotic** events, and **Test** (laboratory confirmation with antibodies). The management involves immediately stopping heparin and considering alternative anticoagulation.

## Correct Answer: D.